Skip to main content
SpringerLink
Log in

Pay increases for executives at private life sciences companies hit a 12-year low

  • Careers and Recruitment
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

In 2011, year-over-year executive cash compensation increased just 1.6%, well below the historical 5% annual rise, according to a nationwide survey.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Cash compensation for life sciences nonfounders.
Figure 2

Acknowledgements

The author would like to thank Evan Brown at extensionEngine LLC (http://www.extensionengine.com/) for his contributions to the CompStudy report and this article.

Author information

Authors and Affiliations

  1. Bruce Rychlik is at J. Robert Scott, Boston, Massachusetts, USA.,

    Bruce Rychlik

Authors
  1. Bruce Rychlik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce Rychlik.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rychlik, B. Pay increases for executives at private life sciences companies hit a 12-year low. Nat Biotechnol 30, 289–291 (2012). https://doi.org/10.1038/nbt.2155

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2155

  • Springer Nature America, Inc.

Search

Navigation